Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.

NASHUA, N.H. and TORONTO, March 05, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer ...

Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...

The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...

Anna Patterson has had a storied career in Silicon Valley. She founded three startups, including search engine upstarts Xift ...

The use of artificial intelligence in the healthcare industry continues to grow. University Hospitals has acquired new ...

Companies like Google say AI can accelerate scientific research. Many experts don't believe that's true, necessarily.

The AI model processes pre-contrast and a single post-contrast T1 image, identifying suspicious regions and assigning a ...

It's not the pace of innovation that limits us, but how society harnesses these advances, says Gemma Peters, chief executive of Macmillan ...

Researchers developed a microfluidic device that sorts breast cancer cells by adhesion strength. Weakly adherent cells were ...